期刊名：Journal of Cardiovascular Development and Disease

期刊主页：https://www.mdpi.com/journal/jcdd

心力衰竭的疾病负担持续加重，已成为全球心血管领域面临的重大公共卫生挑战。本专题汇集了发表于 Journal of Cardiovascular Development and Disease（JCDD）的系列前沿研究，系统展示了从流行病学、行为风险、机制探索到临床管理的心力衰竭全景。欢迎广大心血管领域研究者与临床医生深入阅读本专题相关文章，共同推动心衰诊疗水平的持续提升。本刊所有文章均以开放获取形式出版，可免费供您免费并无限制地阅读全部内容。

1. Cardiometabolic Heart Failure with Preserved Ejection Fraction (HFpEF): Epidemiology, Mechanisms, and the Role of Lifestyle Modification

心血管代谢性射血分数保留型心力衰竭（HFpEF）：流行病学、机制及生活方式干预的作用

https://www.mdpi.com/2308-3425/13/7/291

Yang, D.G.; Thakur, S.; Akunor, H.; Stacey, R.B.; Upadhya, B. Cardiometabolic Heart Failure with Preserved Ejection Fraction (HFpEF): Epidemiology, Mechanisms, and the Role of Lifestyle Modification. J. Cardiovasc. Dev. Dis. 2026, 13, 291. https://doi.org/10.3390/jcdd13070291

2. Acute High Intensity Interval Exercise Promotes Circulating Progenitor Cell Mobilization and Improves Microcirculation in Patients with Chronic Heart Failure

急性高强度间歇运动促进慢性心力衰竭患者循环祖细胞动员并改善微循环

https://www.mdpi.com/2308-3425/13/6/262

Mitsiou, G.; Tokmakidis, S.P.; Patsaki, I.; Psarra, K.; Kourek, C.; Karatzanos, E.; Papathanasiou, G.; Dimopoulos, S. Acute High Intensity Interval Exercise Promotes Circulating Progenitor Cell Mobilization and Improves Microcirculation in Patients with Chronic Heart Failure. J. Cardiovasc. Dev. Dis. 2026, 13, 262. https://doi.org/10.3390/jcdd13060262

3. Multi-Chamber Reverse Remodeling and Hemodynamic Force Realignment After SGLT2 Inhibitor Initiation in Real-World Heart Failure

真实世界心力衰竭患者启动SGLT2抑制剂后的多腔室逆重构与血流动力学力再对齐

https://www.mdpi.com/2308-3425/13/6/260

Prosperi, S.; Monosilio, S.; D’Amato, A.; Angotti, D.; Filomena, D.; Netti, L.; Tonti, G.; Pedrizzetti, G.; Cimino, S.; Badagliacca, R.; et al. Multi-Chamber Reverse Remodeling and Hemodynamic Force Realignment After SGLT2 Inhibitor Initiation in Real-World Heart Failure. J. Cardiovasc. Dev. Dis. 2026, 13, 260. https://doi.org/10.3390/jcdd13060260

4. Well-Known and Novel Behavioural Risk Factors for Heart Failure

已知与新型心力衰竭行为危险因素

https://www.mdpi.com/2308-3425/13/5/211

Kusyn, N.; Zdebik, N.; Hajdusianek, W.; Poreba, R.; Gac, P. Well-Known and Novel Behavioural Risk Factors for Heart Failure. J. Cardiovasc. Dev. Dis. 2026, 13, 211. https://doi.org/10.3390/jcdd13050211

5. Major Aortopulmonary Collateral Artery as a Rare Cause of Heart Failure in a Neonate with Transposition of the Great Arteries: An Unexpected Turn in an Otherwise Routine Case

主肺动脉侧支动脉作为大动脉转位新生儿心力衰竭的罕见病因——一例常规病例中的意外转折

http://mdpi.com/2308-3425/13/5/210

Parezanovic, V.; Andric, D.; Chadikovski, V.; Stojanovikj, V.; Madzoska, J.; Trpkovska, V.; Stefanovic, I. Major Aortopulmonary Collateral Artery as a Rare Cause of Heart Failure in a Neonate with Transposition of the Great Arteries: An Unexpected Turn in an Otherwise Routine Case. J. Cardiovasc. Dev. Dis. 2026, 13, 210. https://doi.org/10.3390/jcdd13050210

6. Clinical and Inflammatory Determinants of Heart Failure Severity Following Myocardial Infarction: Implications for Post-Infarction Care

心肌梗死后心力衰竭严重程度的临床与炎症决定因素——对梗死后管理的启示

https://www.mdpi.com/2308-3425/13/5/197

Buzle, A.M.; Matache, P.; Moisi, M.I.; Cinezan, C.; Ghitea, M.C.; Ghitea, E.C.; Ghitea, T.C.; Ardelean, I.A.; Rus, M.; Brata, R.D.; et al. Clinical and Inflammatory Determinants of Heart Failure Severity Following Myocardial Infarction: Implications for Post-Infarction Care. J. Cardiovasc. Dev. Dis. 2026, 13, 197. https://doi.org/10.3390/jcdd13050197

7. Effect of SGLT2 Inhibitors on the Efficacy of First-Time Pulmonary Vein Isolation and Clinical Course of Patients with Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation

SGLT2抑制剂对射血分数保留型心力衰竭合并心房颤动患者首次肺静脉隔离疗效及临床病程的影响

https://www.mdpi.com/2308-3425/13/4/160

Balwierz-Podgórna, M.; Gruchlik, B.; Mizia-Stec, K.; Filak, A.; Hejmej, A.; Pazdziora, P.; Golda, M.; Spirkowicz, A.; Dzieciol, K.; Wybraniec, M. Effect of SGLT2 Inhibitors on the Efficacy of First-Time Pulmonary Vein Isolation and Clinical Course of Patients with Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation. J. Cardiovasc. Dev. Dis. 2026, 13, 160. https://doi.org/10.3390/jcdd13040160

8. Obesity and Heart Failure: Introducing the Theme

肥胖与心力衰竭——主题导读

https://www.mdpi.com/2308-3425/13/4/153

Monitillo, F.; Basile, P.; Lisco, G. Obesity and Heart Failure: Introducing the Theme. J. Cardiovasc. Dev. Dis. 2026, 13, 153. https://doi.org/10.3390/jcdd13040153

9. Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction

Vericiguat治疗与射血分数降低型慢性心力衰竭患者心肌逆重构相关

https://www.mdpi.com/2308-3425/13/1/17

Bajec, T.; Zorz, N.; Ugovšek, S.; Zemljic, G.; Cerar, A.; Frljak, S.; Okrajšek, R.; Girandon Sušanj, P.; Šebeštjen, M.; Vrtovec, B.; et al. Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction. J. Cardiovasc. Dev. Dis. 2026, 13, 17. https://doi.org/10.3390/jcdd13010017

10. Long-Term Mortality and Survival in Patients with Acute Heart Failure Assessed by Emergency Medical Services

经院前急救评估的急性心力衰竭患者的长期死亡率与生存分析

https://www.mdpi.com/2308-3425/12/12/485

Castro-Portillo, E.; Ramos-Rodríguez, A.; López-Izquierdo, R.; Bermudez-Castellanos, I.; Castro Villamor, M.Á.; Otero de la Torre, S.; Martínez Fernández, F.T.; Sánchez Soberon, I.; Sanz-García, A.; Martín-Rodríguez, F. Long-Term Mortality and Survival in Patients with Acute Heart Failure Assessed by Emergency Medical Services. J. Cardiovasc. Dev. Dis. 2025, 12, 485. https://doi.org/10.3390/jcdd12120485

期刊介绍

Journal of Cardiovascular Development and Disease 是一本国际性、经过严格同行评审的开放获取学术期刊。本刊致力于发表关于心血管发育、先天性心脏病及获得性心脏病领域的高质量研究，旨在为全球科学家提供一个分享与交流的权威平台。主题领域包括但不限于：心血管基础与转化研究，心脏发育与再生，儿科与先天性心脏病，获得性心脏病，电生理学与心律失常，心血管流行病学，心血管成像与诊断，心血管临床研究，心血管外科手术等等。

2025 Impact Factor：2.6

2025 CiteScore：4.5

Time to First Decision：23.4 Days

Acceptance to Publication：3.6 Days